These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6654255)

  • 1. [A comparison of liquid antacids].
    Peled Y; Rattan J; Gilat T
    Harefuah; 1983 Sep; 105(5-6):110-2. PubMed ID: 6654255
    [No Abstract]   [Full Text] [Related]  

  • 2. Magaldrate and almasilate--complex buffering antacids.
    Drug Ther Bull; 1985 May; 23(10):39-40. PubMed ID: 3888581
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antacids: A comparison of their in vitro neutralizing capacity in hydrochloric acid and in acidified peptone solution (author's transl)].
    Walther C; Herzog P; Hissnauer KH; Kühl HJ; Holtermüller KH
    Z Gastroenterol; 1982 May; 20(5):263-72. PubMed ID: 7102017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Do antacids with high acid-binding capacity modify mineral metabolism?].
    Dollinger HC; Holzberg E
    Fortschr Med Suppl; 1987; 19():10-4. PubMed ID: 2883095
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of proteolytic enzymes and polypeptides on the antacid activity of almagate and other antacids.
    Beneyto JE; Fábregas JL
    Arzneimittelforschung; 1984; 34(10A):1357-60. PubMed ID: 6391496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Rennie Liquid versus Maalox Liquid on intragastric pH in a double-blind, randomized, placebo-controlled, triple cross-over study in healthy volunteers.
    Hürlimann S; Michel K; Inauen W; Halter F
    Am J Gastroenterol; 1996 Jun; 91(6):1173-80. PubMed ID: 8651166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium hydroxide/aluminium hydroxide-containing antacid does not affect the pharmacokinetics of the targeted phosphodiesterase 4 inhibitor roflumilast.
    Nassr N; Lahu G; Hünnemeyer A; von Richter O; Knoerzer D; Reutter F; Zech K; Hermann R
    J Clin Pharmacol; 2007 May; 47(5):660-6. PubMed ID: 17374735
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of neutralization capacity of antacids in gastric juice].
    Halter F
    Z Gastroenterol; 1983 Mar; 21 Suppl():33-40. PubMed ID: 6858409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of neutralizing properties of antacid preparations. Part 3: Constant pH neutralization of hydrochloric acid by hydrotalcite.
    Kokot Z
    Pharmazie; 1988 Apr; 43(4):249-51. PubMed ID: 3413211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mineral metabolism and aluminum burden with hydrotalcit. A placebo-controlled randomized double-blind study].
    Dollinger HC
    Fortschr Med; 1991 Jun; 109(18):385-8. PubMed ID: 1916557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evidence of the cytoprotective action of antacids. Behavior of the transmural stomach electric potential difference with antacids in healthy subjects and stomach ulcer patients].
    Tympner F
    Fortschr Med; 1985 Sep; 103(33):795-8. PubMed ID: 4054802
    [No Abstract]   [Full Text] [Related]  

  • 12. Acid-neutralizing capacity and sodium content of antacid products from Belgium.
    Gombatz VW
    Clin Ther; 1984; 6(2):151-4. PubMed ID: 6705010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralizing capacity of particulate antacids.
    Eyler SW; Zaccari J
    Anesthesiology; 1983 Jun; 58(6):591-2. PubMed ID: 6859600
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of two antacid preparations on intragastric acidity--a two-centre open randomised cross-over placebo-controlled trial.
    Sulz MC; Manz M; Grob P; Meier R; Drewe J; Beglinger C
    Digestion; 2007; 75(2-3):69-73. PubMed ID: 17496418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum and urine electrolyte behavior under therapeutic dosage of a potent magnesium and aluminum hydroxide containing antacid].
    Grünzig G; Lücker PW; Schnitker J
    Arzneimittelforschung; 1983; 33(2):258-62. PubMed ID: 6682667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of action of an antacid in two groups of patients.
    González L; Olazábal A
    Bol Asoc Med P R; 1980 Nov; 72(11):574-7. PubMed ID: 7011340
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of antacids and ranitidine on the single-dose pharmacokinetics of fosamprenavir.
    Ford SL; Wire MB; Lou Y; Baker KL; Stein DS
    Antimicrob Agents Chemother; 2005 Jan; 49(1):467-9. PubMed ID: 15616339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The choice of an antacid in therapy: use of in vivo methods].
    Caulin C; Isal JP
    Gastroenterol Clin Biol; 1983 Nov; 7(11):931. PubMed ID: 6653980
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the effects of ranitidine effervescent tablets and magnesium hydroxide-aluminium oxide on intragastric acidity. A single-centre, randomised, open cross-over study.
    Propst A; Propst T; Judmaier G
    Arzneimittelforschung; 1996 Jun; 46(6):621-4. PubMed ID: 8767354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy in vivo of almagate in neutralising histamine-induced acid secretion in a rat re-perfused stomach preparation.
    Llupiá J; Beckett PR; Lumachi B; Roberts DJ
    Arzneimittelforschung; 1984; 34(10A):1370-2. PubMed ID: 6548923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.